期刊文献+

百普乐治疗原发性高血压的疗效观察

下载PDF
导出
摘要 目的观察百普乐治疗原发性高血压的疗效。方法选择门诊就诊的115例血压〉160/100mmHg的高血压病患者,经2周的安慰剂导人期后,给予晨服百普乐4-8mg,观察诊室血压及24h血压及谷峰比值。结果百普乐治疗4周后总有效率94.8%,百普乐能明显降低诊室血压及24h血压(P〈0.01),百普乐降压收缩压谷峰比为(0.85±0.12),舒张压谷峰比为(0.71±0.11),无明显不良反应。结论百普乐降压作用显著,能24h平稳降压,临床应用安全。
出处 《中国医药指南》 2013年第36期409-410,共2页 Guide of China Medicine
  • 相关文献

参考文献1

二级参考文献14

  • 1Ndindjock R, Gedeon J, Meudis S, et al. Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles. Bull World Health Organ, 2011,89: 286-295.
  • 2Wald N J, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ,2003,326 : 1419.
  • 3Carey KM, Comee MR, Donovan JL, et al. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Ann Pharmacother, 2012,46 : 688-695.
  • 4Endres M, Heusehmann PU, Laufs U, et al. Primary prevention of stroke : blood pressure, lipids, and heart failure. Eur Heart J, 2011,32:545-552.
  • 5Rubinstein A, Garcfa Marti S, Souto A, et al. Generalized cost- effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eft Resour Alloc ,2009,7 : 10.
  • 6Zamorano J, Erdine S, Pavia A, et al. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. Curr Med Res Opin,2011,27 : 821-833.
  • 7Indian Polycap Study ( TIPS), Yusuf S, Pais P, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS) : a phase Ⅱ , double-blind, randomised trial. Lancet,2009, 373 : 1341-1351.
  • 8Malekzadeh F, Marshall T, Pourshams A, et al. A pilot double- blind randomised placebo-controlled trial of the effects of fixed- dose combination therapy ("polypill ") on cardiovascular risk factors. Int J Clin Pract,2010, 64 : 1220-1227.
  • 9Soliman EZ, Mendis S, Dissanayake WP, et al. A Poiypill for primary prevention of cardiovascular disease : a feasibility study of the World Health Organization. TriMs,2011,12:3.
  • 10PILL Collaborative Group, Rodgers A, Patel A, et al. An international randomised placebo-controlled trial of a four- component combination pill (" polypill") in people with raised cardiovascular risk. PLoS One,2011,6 : e19857.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部